Session: New insights into the development and progression of kidney disease in sickle cell disease
Pathophysiology of kidney disease in sickle cell disease and sickle cell trait
Friday, May 3, 2024
5:15 PM – 5:40 PM ET
Location: Metro Toronto Convention Centre: 801 B
Speaker(s)
Kenneth I. Ataga, MD
Professor & Director UTHSC at Memphis Memphis, Tennessee, United States
Disclosure(s):
Kenneth I. Ataga, MD: Agios Pharmaceuticals (Ongoing) (Products/Services: Advisory Committee); Biomarin (Terminated, January 31, 2024) (Products/Services: Advisory Committee, Consultant); Fulcrum Therapeutics (Ongoing) (Products/Services: Advisory Committee); GSK (Ongoing) (Products/Services: Advisory Committee); Hillhurst Biopharmaceuticals (Ongoing) (Products/Services: Advisory Committee); Novartis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Novo Nordisk (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Advisory Committee); Sanofi (Ongoing) (Products/Services: Advisory Committee)
